πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,444 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10016461

Apparatus and process for growing a heart valve in three-dimensions

The Regents of the University of California Β· Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10016388

Ophthalmic lens, intraocular lens, and ophthalmic lens package having ophthalmic lens

HON HAI PRECISION INDUSTRY CO., LTD. Β· Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10004699

Methods and compositions for interfering with extraction or conversion of a drug susceptib

Acurx Pharmaceuticals, Inc. Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10006025

Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin

Arrowhead Pharmaceuticals, Inc. Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10006052

Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and u

PRECISION GENOME ENGINEERING, INC. Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10000746

LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereof

PRECISION GENOME ENGINEERING, INC. Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9994855

Compositions and methods for modulating growth hormone receptor expression

Ionis Pharmaceuticals, Inc. Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9993502

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9993501

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9988630

Methods and compositions for the specific inhibition of gene expression by double-stranded

INTEGRATED DNA TECHNOLOGIES, INC. Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9980931

Use of glycyl glutamine against depression

Uludag Universitesi Teknoloji Transfer Ofisi Ticaret Ve Sanayi Anonim Suirketi Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9977021

CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs

The Regents of the University of California Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9976141

Compositions and methods for inhibiting gene expression of Hif2alpha

Arrowhead Pharmaceuticals, Inc. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9976138

Methods and compounds useful in conditions related to repeat expansion

Ionis Pharmaceuticals, Inc. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9976123

Cellular seeding and co-culture of a three dimensional fibroblast construct

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9975952

Antibody fragments, compositions and uses thereof

METIS PRECISION MEDICINE SB S.R.L. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9975926

Methods of making and using vaccines utilizing minicircle DNA expression vectors for produ

The United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974794

Emulsion formulations of aprepitant

Heron Therapeutics, Inc. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974793

Emulsion formulations of aprepitant

Heron Therapeutics, Inc. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974742

Emulsion formulations of an NK-1 receptor antagonist and uses thereof

Heron Therapeutics, Inc. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9970006

Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) gene

Alnylam Pharmaceuticals, Inc. Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9969975

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9968693

Small molecule imaging of fungi by positron emission tomography scanning

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9968664

Fusion molecule based on novel TAA variant

The Regents of the University of California Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted